Yseop automates and translates data into actionable language, enabling the simplification of once complex workflows.
Yseop’s AI-based technologies generate core elements of specialist medical reports, including clinical study reports (CSR), patient narratives, and more.
Deliver highly accurate narratives by automating parts of the preclinical document review cycle.
Yseop is thrilled to announce that we have been nominated for The World Technology Leader Award. We are in the company of prestigious nominees including OpenAI, BMW, and BASF.
Reimagining the future of scientific writing, Yseop Copilot leverages pre-trained cutting edge Generative AI models (LLMs) for the BioPharma industry.
Yseop has won at the 2023 Citeline Awards for Best Use of Artificial Intelligence in Clinical Trials.
Yseop has been honored as a finalist in the 2023 Global Business Tech Awards for the Best Use of Artificial Intelligence in Clinical Trials.
Read the full article in Pharmaphorum. Across all industries, generative AI has become the latest buzz word. Talk of implementing automation and AI solutions to enhance human capacity continues to dominate conversations. In fact, venture capitalists have increased investment in generative AI by 425% since 2020 to $2.1 billion.
Yseop has been honored As finalist in the 2023 Citeline Awards for the Best Use of Artificial Intelligence in Clinical Trials.
The top natural language generation companies in 2023. NLG has become popular in recent years due to its content creation ability.
NEW YORK, NY, February, 2023 – This article was originally featured in Enterprisetalk. Without a human-centric approach, OpenAI ChatGPT runs on the data available on the various channels, which can also deliver services without meeting the context requirements. Sometimes, it writes plausible-sounding content but can be trustworthy. The new kid on the block, AI-powered ChatGPT …
Yseop’s Augmented Analyst eliminates up to 50% of time spent on reporting tasks across all of corporate finance.
After four successful years of collaborating, Sanofi plans to expand Yseop’s platform for pharma and vaccine use cases.
